MK-8931: Alzheimer's Drug Trial Starts Today
Dec 3 (Reuters) - Merck & Co Inc said on Monday it started a new clinical trial to evaluate the safety and effectiveness
mk alzheimer drug trial start today dec reuters merck co inc say monday start new clinical trial evaluate safety effectiveness